Home  >  Products  >  CASQ2 (calsequestrin 2 (cardiac muscle) ) Blocking Peptide (the N terminal of CASQ2)(100ug)
CASQ2 (calsequestrin 2 (cardiac muscle) ) Blocking Peptide (the N terminal of CASQ2)(100ug)

CASQ2 (calsequestrin 2 (cardiac muscle) ) Blocking Peptide (the N terminal of CASQ2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CASQ2 Antibody (ARP63849_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63849
Size: 100ug
Weight: 46kDa
Gene: 845
Format: Lyophilized powder
Target: The protein encoded by this gene specifies the cardiac muscle family member of the calsequestrin family. Calsequestrin is localized to the sarcoplasmic reticulum in cardiac and slow skeletal muscle cells. The protein is a calcium binding protein that stores calcium for muscle function. Mutations in this gene cause stress-induced polymorphic ventricular tachycardia, also referred to as catecholaminergic polymorphic ventricular tachycardia 2 (CPVT2), a disease characterized by bidirectional ventricular tachycardia that may lead to cardiac arrest.
Alternative names: FLJ26321; FLJ93514; PDIB2
See Full Product Listings >